193 related articles for article (PubMed ID: 10372114)
1. Stem cell gene therapy for the beta-chain hemoglobinopathies. Problems and progress.
Emery DW; Stamatoyannopoulos G
Ann N Y Acad Sci; 1999 Apr; 872():94-107; discussion 107-8. PubMed ID: 10372114
[TBL] [Abstract][Full Text] [Related]
2. Development of virus vectors for gene therapy of beta chain hemoglobinopathies: flanking with a chromatin insulator reduces gamma-globin gene silencing in vivo.
Emery DW; Yannaki E; Tubb J; Nishino T; Li Q; Stamatoyannopoulos G
Blood; 2002 Sep; 100(6):2012-9. PubMed ID: 12200360
[TBL] [Abstract][Full Text] [Related]
3. Gene Therapy for Hemoglobinopathies.
Cavazzana M; Mavilio F
Hum Gene Ther; 2018 Oct; 29(10):1106-1113. PubMed ID: 30200783
[TBL] [Abstract][Full Text] [Related]
4. Advances in stem cell transplantation and gene therapy in the β-hemoglobinopathies.
Payen E; Leboulch P
Hematology Am Soc Hematol Educ Program; 2012; 2012():276-83. PubMed ID: 23233592
[TBL] [Abstract][Full Text] [Related]
5. Ex Vivo Selection of Transduced Hematopoietic Stem Cells for Gene Therapy of β-Hemoglobinopathies.
Bhukhai K; de Dreuzy E; Giorgi M; Colomb C; Negre O; Denaro M; Gillet-Legrand B; Cheuzeville J; Paulard A; Trebeden-Negre H; Borwornpinyo S; Sii-Felice K; Maouche L; Down JD; Leboulch P; Payen E
Mol Ther; 2018 Feb; 26(2):480-495. PubMed ID: 29221807
[TBL] [Abstract][Full Text] [Related]
6. Gene Therapy Approaches to Hemoglobinopathies.
Ferrari G; Cavazzana M; Mavilio F
Hematol Oncol Clin North Am; 2017 Oct; 31(5):835-852. PubMed ID: 28895851
[TBL] [Abstract][Full Text] [Related]
7. A New Era for Hemoglobinopathies: More Than One Curative Option.
Psatha N; Papayanni PG; Yannaki E
Curr Gene Ther; 2017; 17(5):364-378. PubMed ID: 29357790
[TBL] [Abstract][Full Text] [Related]
8. Globin gene transfer for the treatment of severe hemoglobinopathies: a paradigm for stem cell-based gene therapy.
Sadelain M
J Gene Med; 2002; 4(2):113-21. PubMed ID: 11933212
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for human hemoglobinopathies.
Walsh CE; Liu JM; Miller JL; Nienhuis AW; Samulski RJ
Proc Soc Exp Biol Med; 1993 Dec; 204(3):289-300. PubMed ID: 8234372
[TBL] [Abstract][Full Text] [Related]
10. Preselection of retrovirally transduced bone marrow avoids subsequent stem cell gene silencing and age-dependent extinction of expression of human beta-globin in engrafted mice.
Kalberer CP; Pawliuk R; Imren S; Bachelot T; Takekoshi KJ; Fabry M; Eaves CJ; London IM; Humphries RK; Leboulch P
Proc Natl Acad Sci U S A; 2000 May; 97(10):5411-5. PubMed ID: 10792053
[TBL] [Abstract][Full Text] [Related]
11. Stem cell engineering for the treatment of severe hemoglobinopathies.
Sadelain M; Boulad F; Lisowki L; Moi P; Riviere I
Curr Mol Med; 2008 Nov; 8(7):690-7. PubMed ID: 18991654
[TBL] [Abstract][Full Text] [Related]
12. Development of a condensed locus control region cassette and testing in retrovirus vectors for A gamma-globin.
Emery DW; Chen H; Li Q; Stamatoyannopoulos G
Blood Cells Mol Dis; 1998 Sep; 24(3):322-39. PubMed ID: 10087991
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy for the hemoglobin disorders.
Persons DA; Tisdale JF
Semin Hematol; 2004 Oct; 41(4):279-86. PubMed ID: 15508113
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy of hemoglobinopathies: progress and future challenges.
Ikawa Y; Miccio A; Magrin E; Kwiatkowski JL; Rivella S; Cavazzana M
Hum Mol Genet; 2019 Oct; 28(R1):R24-R30. PubMed ID: 31322165
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for hemoglobinopathies: are we there yet?
Puthenveetil G; Malik P
Curr Hematol Rep; 2004 Jul; 3(4):298-305. PubMed ID: 15217560
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for the hemoglobin disorders.
Persons DA; Nienhuis AW
Curr Hematol Rep; 2003 Jul; 2(4):348-55. PubMed ID: 12901333
[TBL] [Abstract][Full Text] [Related]
17. Manipulation of Developmental Gamma-Globin Gene Expression: an Approach for Healing Hemoglobinopathies.
Venkatesan V; Srinivasan S; Babu P; Thangavel S
Mol Cell Biol; 2020 Dec; 41(1):. PubMed ID: 33077498
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders.
Persons DA
Hematology Am Soc Hematol Educ Program; 2009; ():690-7. PubMed ID: 20008255
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy for hemoglobinopathies: the state of the field and the future.
Chandrakasan S; Malik P
Hematol Oncol Clin North Am; 2014 Apr; 28(2):199-216. PubMed ID: 24589262
[TBL] [Abstract][Full Text] [Related]
20. Gene Therapy for beta-thalassemia.
Malik P; Arumugam PI
Hematology Am Soc Hematol Educ Program; 2005; ():45-50. PubMed ID: 16304358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
